News

President Obama Nominates Mack Roach to National Cancer Advisory Board

President Obama Nominates Mack Roach to National Cancer Advisory Board

December 11, 2012

President Barack Obama announced his intent to nominate UCSF's Mack Roach III, MD, FACR, an internationally recognized expert on using radiation to treat and manage prostate cancer, to the National Cancer Advisory Board.

Cancer, Genetic Risks and Precision Medicine Highlighted at Showcase

Cancer, Genetic Risks and Precision Medicine Highlighted at Showcase

December 6, 2012

Precision medicine and cancer genetics were among the topics discussed during 11 breakout sessions guided by 30 UCSF faculty members at the Nov. 7 showcase for the UCSF Helen Diller Family Comprehensive Cancer Center.

image

Cancer Survival Rates Will Be Boosted by Drug Development

December 6, 2012

The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.

Cancer Services in Tri-Valley Enhanced by New UCSF-ValleyCare Collaboration

Cancer Services in Tri-Valley Enhanced by New UCSF-ValleyCare Collaboration

December 4, 2012

The Regional Cancer Center at ValleyCare and UCSF Helen Diller Family Comprehensive Cancer Center have joined forces to enhance patient care and improve access to top level medical experts.

Betting on Harry: Boy Diagnosed With Leukemia Receives Life-Saving Treatment

Betting on Harry: Boy Diagnosed With Leukemia Receives Life-Saving Treatment

December 3, 2012

As the parent of a bone marrow transplant patient, there are a few milestones that you long for your child to reach. 

NIH Grant Supports Collaborative Oral Cancer Research

NIH Grant Supports Collaborative Oral Cancer Research

November 30, 2012

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) has awarded nearly half a million dollars to the Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF) for a collaborative research project that includes New York University (NYU), Oregon Health and Science University (OHSU), and Providence Cancer Center.